Compile Data Set for Download or QSAR
maximum 50k data
Found 7 Enz. Inhib. hit(s) with Target = 'Glutamate receptor ionotropic, NMDA 2B' and Ligand = 'BDBM287603'
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287603(BDBM393497 | BDBM413611 | BDBM617007 | US9567341, ...)
Affinity DataKi:  0.838nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287603(BDBM393497 | BDBM413611 | BDBM617007 | US9567341, ...)
Affinity DataIC50:  23nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287603(BDBM393497 | BDBM413611 | BDBM617007 | US9567341, ...)
Affinity DataIC50:  23nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287603(BDBM393497 | BDBM413611 | BDBM617007 | US9567341, ...)
Affinity DataIC50:  23nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287603(BDBM393497 | BDBM413611 | BDBM617007 | US9567341, ...)
Affinity DataIC50:  23nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287603(BDBM393497 | BDBM413611 | BDBM617007 | US9567341, ...)
Affinity DataIC50:  23nMpH: 7.35Assay Description:The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37° C. in a humidified CO2 incubator in the grow...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM287603(BDBM393497 | BDBM413611 | BDBM617007 | US9567341, ...)
Affinity DataIC50:  23nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent